Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/jgh.12160

http://scihub22266oqcxt.onion/10.1111/jgh.12160
suck pdf from google scholar
23425082!?!23425082

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=23425082&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid23425082      J+Gastroenterol+Hepatol 2013 ; 28 (7): 1187-93
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy #MMPMID23425082
  • Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
  • J Gastroenterol Hepatol 2013[Jul]; 28 (7): 1187-93 PMID23425082show ga
  • BACKGROUND: Minimal hepatic encephalopathy (MHE) represents the mildest form of hepatic encephalopathy (HE), with abnormal neuropsychologic findings. Inflammatory response may be important in the pathogenesis of MHE. On magnetic resonance spectroscopy (MRS), improvement of metabolic ratios after liver transplantation suggests an important role of myoinositol (mI) and choline (cho) in the development of MHE. AIMS: To investigate arterial ammonia, tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-6, IL-18, serum endotoxin, and MRS before and after treatment in MHE. PATIENTS AND METHODS: Sixty patients of cirrhosis with MHE were randomized to two groups, Gr. MHE-L (n = 30), treated with lactulose for 3 months, and Gr. MHE-NL (n = 30), who did not received lactulose. Arterial ammonia, TNF-alpha, IL-6, IL-18, serum endotoxin, and MRS were performed in all patients at baseline and at 3 months and 20 patients of cirrhosis without MHE and 20 healthy controls. RESULTS: After 3 months, median arterial ammonia (69.4 vs 52.7 mcg/dL), TNF-alpha (26.6 vs 22 pg/mL), IL-6 (17.6 vs 12.4 pg/mL), IL-18 (42.5 vs 29 pg/mL), and serum endotoxin (0.68 vs 0.43 EU/mL) significantly decreased in Gr. MHE-L compared with baseline (P < 0.0001), while no change was seen in Gr. MHE-NL patients. On MRS, compared with patients of cirrhosis without MHE, mI and cho were significantly lower (P < 0.001) and glutamine (Glx) was significantly higher in both MHE groups (P < 0.001). After 3 months, mI and cho increased and Glx decreased significantly in Gr. MHE-L (P < 0.001), without changes in Gr. MHE-NL patients. Psychometric hepatic encephalopathic score (PHES) correlated well with arterial ammonia, TNF-alpha, IL-6, IL-18, serum endotoxin, and metabolic parameters on MRS. CONCLUSIONS: Arterial ammonia, inflammatory mediators (TNF-alpha, IL-6, IL-18), and serum endotoxin reduce and MRS abnormalities improve after treatment with lactulose in patients with MHE.
  • |*Magnetic Resonance Spectroscopy[MESH]
  • |Adolescent[MESH]
  • |Adult[MESH]
  • |Aged[MESH]
  • |Ammonia/blood[MESH]
  • |Biomarkers/blood[MESH]
  • |Endotoxins/*blood[MESH]
  • |Female[MESH]
  • |Gastrointestinal Agents/*therapeutic use[MESH]
  • |Hepatic Encephalopathy/*diagnosis/*drug therapy/etiology[MESH]
  • |Humans[MESH]
  • |Inflammation Mediators/blood[MESH]
  • |Interleukin-18/blood[MESH]
  • |Interleukin-6/blood[MESH]
  • |Lactulose/*therapeutic use[MESH]
  • |Liver Cirrhosis/complications[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Tumor Necrosis Factor-alpha/blood[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box